CHROMIUM SODIUM BIS(2-CHLORO-4-((4,5-DIHYDRO-3-METHYL-5-OXO-1-PHENYL-1H-PYRAZOL-4-YL)AZO)-5-HYDROXYBENZENESULFONAMIDE
UNII 3LBB41R06C
Substance Identification & Data
This profile provides standardized clinical and technical data for Chromium Sodium Bis(2-chloro-4-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1h-pyrazol-4-yl)azo)-5-hydroxybenzenesulfonamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3LBB41R06C.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 67109-27-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
2C16H12ClN5O4S.Cr.Na MTEWSKPSJGGDQE-NAYDCRHMSA-J Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Chromium Sodium Bis(2-chloro-4-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1h-pyrazol-4-yl)azo)-5-hydroxybenzenesulfonamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.